Chair(s): Refika Hamutcu Ersu, Athanasios G. Kaditis
Session type: Symposium
Session content
Replay
Jessica Taytard
Replay
Slides
Hui Leng Tan
Replay
Slides
Anita Simonds
Replay
Slides
Discussion and Q&A
Replay
Session aims
Genetic neuromuscular diseases constitute a heterogeneous group of rare conditions, including some of the most disabling conditions in childhood. Recently, advanced technologies have greatly expanded preclinical and clinical research, and specific therapies have been developed. This symposium will start with a review of current developments in management of these children who are at increased risk of sleep related hypoventilation and obstructive sleep apnoea. Another group of children who are at risk for sleep disordered breathing is children with neuro-disability. The second talk will address the diagnostic and treatment challenges in these children. It is challenging to transition the care of these children with medical complexity to adult care and the third talk will concentrate on the road map for successful transition.